PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
3.360
-0.020 (-0.59%)
Aug 29, 2025, 3:57 PM - Market open
PolyPid Market Cap
PolyPid has a market cap or net worth of $52.60 million as of August 29, 2025. Its market cap has increased by 213.26% in one year.
Market Cap
52.60M
Enterprise Value
31.66M
1-Year Change
213.26%
Ranking
Category
Stock Price
$3.36
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $82.43M to $52.60M, a decrease of -36.19%. That is a compound annual growth rate of -8.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 52.91M | 155.82% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | 183.09M | 122.11% |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.76B |
| Johnson & Johnson | 425.05B |
| AbbVie | 368.08B |
| UnitedHealth Group | 272.09B |
| AstraZeneca | 248.21B |
| Novartis AG | 243.97B |
| Novo Nordisk | 243.46B |
| Abbott Laboratories | 229.03B |